AnPac Bio-Medical Science Co., Ltd.

ANPCNASDAQHealthcare

$4.30

$-0.14(-3.15%)

Market Cap$26974846

P/E Ratio—

52W High$11.99

52W Low$2.6

Avg Volume21K

Open$4.57

Beta1.56

Overview

Foreign Private Issuer · Files 20-F / 6-K

AnPac Bio-Medical Science Co., Ltd. (ANPC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001786511 · ANPC · NASDAQ · as of Jun 9, 2026

Filing snapshot

190

Total Filings

25-NSE

Latest Form

2025-06-17

Most Recent

2020

Filing Since

Financials Earnings View All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001786511 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY

Filed Date

2023-05-16

Fiscal Year End

May 16, 2023

Accession No.

0001213900-23-040488

Primary Document

f20f2022_fresh2group.htm

View on SEC EDGAR Download PDF Filing Index

Source: data.sec.gov · CIK 0001786511 · Accession 0001213900-23-040488

Latest Key Filings

6-KQuarterly Report

REPORT OF FOREIGN PRIVATE ISSUER

2025-04-17

View 6-K on SEC

8-KCurrent Report

CURRENT REPORT

2024-06-26Material Event

View 8-K on SEC

Form 4Insider Activity

Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144

Filed Date

Form Type

Description

View

2025-06-17

25-NSE

0001354457-25-000543

View

25-NSE25-NSE

25-NSE

2025-06-17

View

2025-04-17

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-25-032684

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2025-04-17

View

2025-04-02

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-25-027986

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2025-04-02

View

2024-12-23

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-24-111881

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2024-12-23

View

2024-11-14

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-24-098460

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2024-11-14

View

2024-07-24

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001013762-24-000709

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2024-07-24

View

2024-06-26

8-K

Current Report

CURRENT REPORT

0001213900-24-055915

View

8-KCurrent Report

CURRENT REPORT

2024-06-26

View

2024-06-24

F-6 POS

0001193805-24-000846

View

F-6 POSF-6 POS

F-6 POS

2024-06-24

View

2024-05-23

8-K

Current Report

CURRENT REPORT

0001213900-24-046337

View

8-KCurrent Report

CURRENT REPORT

2024-05-23

View

2024-04-22

8-K

Current Report

CURRENT REPORT

0001213900-24-034664

View

8-KCurrent Report

CURRENT REPORT

2024-04-22

View

2024-04-02

8-K

Current Report

CURRENT REPORT

0001213900-24-029345

View

8-KCurrent Report

CURRENT REPORT

2024-04-02

View

2024-04-02

UPLOAD

0000000000-24-003535

View

UPLOADUPLOAD

UPLOAD

2024-04-02

View

2024-04-02

NT 10-K

NOTIFICATION OF LATE FILING

0001213900-24-029075

View

NT 10-KNT 10-K

NOTIFICATION OF LATE FILING

2024-04-02

View

2024-03-27

8-K

Current Report

CURRENT REPORT

0001213900-24-026601

View

8-KCurrent Report

CURRENT REPORT

2024-03-27

View

2024-03-25

8-K

Current Report

CURRENT REPORT

0001213900-24-025531

View

8-KCurrent Report

CURRENT REPORT

2024-03-25

View

Showing 1–15 of 190 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov) | Updated: Hourly | CIK: 0001786511 | Exchange: NASDAQ · Healthcare

AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) has submitted 190 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001786511, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is AnPac Bio-Medical Science Co., Ltd.'s most comprehensive regulatory disclosure. The most recent AnPac Bio-Medical Science Co., Ltd. 10-K was filed on 2023-05-16 for fiscal year ending 2023. Historical ANPC 10-K annual reports are available from 2019 through 2023.

Investors researching AnPac Bio-Medical Science Co., Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Related Companies SEC Filings — Healthcare

MRNS SEC Filings →ANGN SEC Filings →ALLK SEC Filings →FRLN SEC Filings →LMNL SEC Filings →LSB SEC Filings →GMTX SEC Filings →ELEV SEC Filings →

→ ANPC Financials → ANPC Earnings → ANPC Insider Trades

Frequently Asked Questions

ANPC SEC Filings · 8 questions

AnPac Bio-Medical Science Co., Ltd. (ANPC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 190 filings and access original documents at no cost. AnPac Bio-Medical Science Co., Ltd.'s CIK is 0001786511.

ANPC SEC filingsAnPac Bio-Medical Science Co., Ltd. SEC documentsfind ANPC 10-K